Comprehensive Non-Alcoholic Steatohepatitis (NASH) Market Analysis 2024: Size, Share, And Key Trends
Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
What Growth Rate Can Be Expected in the Non-Alcoholic Steatohepatitis (NASH) Market from 2024 Through 2033?
The market size for non-alcoholic steatohepatitis (NASH) has seen a massive expansion in recent times. The forecast predicts an increase from $3.33 billion in 2023 to $4.54 billion in 2024 with a whopping compound annual growth rate (CAGR) of 36.3%. Factors contributing to the growth in the historical period include an increased occurrence of NASH, the obesity crisis, heightened awareness and diagnosis, alterations in lifestyle and dietary habits, and the development of healthcare infrastructure.
In the coming years, the market size for non-alcoholic steatohepatitis (NASH) is anticipated to experience significant expansion, reaching $14.53 billion by 2028, increasing at a compound annual growth rate (CAGR) of 33.7%. This projected growth during the forecast period can be linked to progress in the development of NASH drugs, an upswing in NASH screening drives, increased spending on healthcare, collaborative research activities, and government backing and regulations. The forecast period is also expected to witness a surge in lifestyle intervention and patient education, heightened cooperation in clinical research, advancements in regulatory procedures and pathway designations, and the incorporation of artificial intelligence in disease diagnosis and monitoring.
Claim Your Free Sample of the Global Non-Alcoholic Steatohepatitis (NASH) Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=8805&type=smp
What Dynamics Are Shaping the Growth of the non-alcoholic steatohepatitis (nash) Market?
The surge in obesity cases is triggering increased demand for the non-alcoholic steatohepatitis (NASH) market. Obesity, defined as uncontrolled or inordinate fat accumulation that poses health risks and is associated with body weights exceeding standard healthy levels for a given height. The prevalence of non-alcoholic fatty liver disease, due to the deepening obesity pandemic, is predicted to make NASH the predominant cause of severe liver disease in the impending years, thus driving demand for NASH treatment and associated drugs. As an illustration, a report titled ‘COVID-19 and Obesity: The 2021 Atlas’, published by the UK-based World Obesity Federation in April 2021, indicated that over 60% of the US population were overweight adults. By 2025, it predicted that the obesity percentage would reach 44.2% among males and 44.4% among females in the US population. Consequently, the escalation in obesity cases will stimulate the expansion of the Non-Alcoholic Steatohepatitis (NASH) market.
What Are the Essential Segments of the Non-Alcoholic Steatohepatitis (NASH) Market?
1) By Type: Solid, Liquid
2) By Product: Vitamin E and Pioglitazone, Ocaliva, Elafibranor, Selonsertib and Cenicriviroc, Other Products
3) By Disease Cause: Hypertension, Heart Disease, High Blood Lipid, Type 2 Diabetes, Obesity
4) By Sales Channel: Hospital Pharmacy, Retail Pharmacy, Online Provider
5) By Application: Oral, Parenteral
What Are the Defining Trends in the Evolving Non-Alcoholic Steatohepatitis (NASH) Market?
Order Now for Fast Delivery of Your Non-Alcoholic Steatohepatitis (NASH) Market Report!
Which Regions Are Emerging as Leaders in the Non-Alcoholic Steatohepatitis (NASH) Market?
North America was the largest region in the non alcoholic steatohepatitis (NASH) market share in 2023. The regions covered in the non-alcoholic steatohepatitis (nash) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The Non-Alcoholic Steatohepatitis (NASH) Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the non-alcoholic steatohepatitis (nash) market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Non-Alcoholic Steatohepatitis (NASH) Market Include
1. Non-Alcoholic Steatohepatitis (NASH) Market Executive Summary
2. Non-Alcoholic Steatohepatitis (NASH) Market Segments
3. Non-Alcoholic Steatohepatitis (NASH) Market Size And Template Market Growth Rate
4. Key Non-Alcoholic Steatohepatitis (NASH) Market Trends
5. Major Non-Alcoholic Steatohepatitis (NASH) Market Drivers
……
25. Key Mergers And Acquisitions In The Non-Alcoholic Steatohepatitis (NASH) Market
26. Top Non-Alcoholic Steatohepatitis (NASH) Companies
27. Non-Alcoholic Steatohepatitis (NASH) Market Opportunities And Strategies
28. Non-Alcoholic Steatohepatitis (NASH) Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Probiotics Dietary Supplements Global Market Report 2024
Digestive Health Supplements Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/digestive-health-supplements-global-market-report
Weight Loss Supplements Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/weight-loss-supplements-global-market-report
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
